Your browser doesn't support javascript.
loading
CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis.
Nawas, Mariam T; Lee, Jeong-Ok; Flynn, Jessica; Maloy, Molly; Jakubowski, Ann A; Papadopoulos, Esperanza B; Cho, Christina; Ponce, Doris M; Sauter, Craig S; Perales, Miguel-Angel; Devlin, Sean; Giralt, Sergio A; Castro-Malaspina, Hugo R; Tamari, Roni.
Afiliación
  • Nawas MT; Hematopoietic Cellular Therapy Program, Department of Medicine, University of Chicago Medicine, Chicago, IL, USA.
  • Lee JO; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Flynn J; Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Maloy M; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Jakubowski AA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Papadopoulos EB; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Cho C; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ponce DM; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Sauter CS; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Perales MA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Devlin S; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Giralt SA; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
  • Castro-Malaspina HR; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Tamari R; Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
Bone Marrow Transplant ; 57(7): 1101-1107, 2022 07.
Article en En | MEDLINE | ID: mdl-35484207
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mielofibrosis Primaria / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Mielofibrosis Primaria / Enfermedad Injerto contra Huésped Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos